Show Notes
N4 Pharma Plc (AIM: N4P), provide details of its work plan following the encouraging data from its oncology research as announced on 13 December 2021. The company sounded very positive with the update released this week.
Share talk spoke with Nigel Theobald, covering the latest announcement and asking him about the market response to news being released by the company, current share price and how often do they have to update the markets?
Have you fully funded all current work streams in Q1/2 in 2022, yes we have more than sufficient funds to carry out the work planned, just a few of the topics raised in the podcast.
https://www.share-talk.com/nigel-theobald-chief-executive-officer-n4-pharma-plc-lonn4p-interview/
https://www.share-talk.com/nigel-theobald-chief-executive-officer-n4-pharma-plc-lonn4p-interview/
Listen On
Also Listen
-
Zak Mir talks to Sath Ganesarajah, CEO of Bluebird Mining Ventures Ltd
Zak Mir talks to Sath Ganesarajah, CEO of Bluebird Mining Ventures Ltd (BMV), a -
Zak Mir talks to Alexander Selegenev, Executive Director, TMT Investments
-
Zak Mir talks to Alexander Selegenev, Executive Director, TMT Investments
Zak Mir talks to Alexander Selegenev, Executive Director, TMT Investments, in t -
Zak Mir talks to Howard White, Chairman of Hydrogen Utopia
Zak Mir talks to Howard White, Chairman Hydrogen Utopia, in the wake of a report